Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established Biomarkers-Reference-Cited by-同舟云学术

Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established Biomarkers

Published:2016-11-18 Issue:11 Volume:11 Page:e0167001
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Irvine Katharine M.,Wockner Leesa F.,Hoffmann Isabell,Horsfall Leigh U.,Fagan Kevin J.,Bijin Veonice,Lee Bernett,Clouston Andrew D.,Lampe Guy,Connolly John E.,Powell Elizabeth E.

Funder

Pathology Queensland

Australian Liver Foundation

National Health and Medical Research Council

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness;C Stasi;World J Gastroenterol,2016

2. Serum markers detect the presence of liver fibrosis: a cohort study;WM Rosenberg;Gastroenterology,2004

3. FibroTest-ActiTest as a non-invasive marker of liver fibrosis;P Halfon;Gastroenterologie clinique et biologique,2008